Active Pharmaceutical Ingredient

Gliclazide

Also known as: Diamicron

CAS: 21187-98-4 Sulfonylurea / Antidiabetic IP / BP / EP / USP GMP Certified Aurangabad, Maharashtra, India
Gliclazide API — Mediocon Inc
Gliclazide — Pharmaceutical Grade API

Product Overview

CAS No: 21187-98-4  |  MF: C15H21N3O3S  |  MW: 323.41 g/mol

Gliclazide is a second-generation sulfonylurea antidiabetic agent with additional antioxidant properties. It is used in the management of type 2 diabetes mellitus. Mediocon Inc supplies pharmaceutical-grade Gliclazide API with full pharmacopoeial compliance.

Key Features

  • Sulfonylurea with antioxidant properties
  • Selective pancreatic beta-cell stimulation
  • IP/BP/EP/USP compliant
  • Full CoA and MSDS documentation

Applications

  • Type 2 diabetes mellitus
  • Oral antidiabetic formulations
  • Modified-release tablet production
  • Combination therapy regimens

Why Choose Mediocon

  • ISO 9001:2015 & GMP certified manufacturing
  • Consistent batch-to-batch quality with full CoA
  • Export-ready documentation: COO, MSDS, DMF
  • Flexible MOQ for both R&D and commercial scale
  • Dedicated QA support for regulatory filings

Product Specifications

Product NameGliclazide
Also Known AsDiamicron
CAS Number21187-98-4
Molecular FormulaC15H21N3O3S
Molecular Weight323.41 g/mol
CategorySulfonylurea / Antidiabetic
AppearanceWhite crystalline powder
GradeIP / BP / EP / USP

Analytical Specifications

ParameterSpecification
Assay≥98.0% (as per pharmacopoeia)
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Packing25 kg HDPE drums / as per requirement
💬
Mediocon AI
Hello 👋 How can I help you today?